Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US EPA to OK Dow's Enlist Duo

The US EPA has proposed the approval of Dow AgroSciences' herbicide, Enlist Duo (2,4-D choline 192 g/litre + glyphosate 204 g/litre), for use on genetically modified herbicide-tolerant Enlist maize (DAS40278) and Enlist soybeans (DAS68416). The proposed use would expand the current timing of applications of 2,4-D on maize and soybeans. It would allow applications of the 2,4-D choline salt formulation on maize up to 4 ft (1.2 m) tall and post-emergence applications to soybeans. 2,4-D is currently approved for use on maize up to 8 inches (0.2 m) tall and for pre-plant applications to soybeans. 2,4-D choline is less prone to drift and volatilisation than other forms of the herbicide, the EPA notes. The USDA has proposed the deregulation of Dow's Enlist maize and soybeans but there has been considerable opposition to the move (Agrow No 685, p 18). The EPA intends to wait until the USDA's review is complete before making a final decision on Enlist Duo. The proposed approval is open to public comment until May 30th.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG001808

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel